Literature DB >> 12210604

Mapping of antibody responses to the protective antigen of Bacillus anthracis by flow cytometric analysis.

Douglas S Reed1, Jennifer Smoll, Paul Gibbs, Stephen F Little.   

Abstract

BACKGROUND: Knowledge of the target and functional capability of the antibody response against an antigen provides more specific and relevant information about protective immunity than measuring the total amount of antibody produced against an antigen.
METHODS: Using flow cytometry, a competitive assay has been created for measuring the antibody response against important epitopes of an antigen. Monoclonal antibodies (mAbs) against the protective antigen (PA) component of Bacillus anthracis are available that neutralize the activity of lethal toxin (LeTx). Flow cytometric analysis revealed that these mAbs bind PA conjugated to polystyrene latex microspheres.
RESULTS: Unlabeled mAbs against PA competed with fluorescent mAbs that bind the homologous epitope but not with fluorescent mAbs that bind heterologous epitopes. Four-parameter logistic models were developed for measuring the antibody response against two epitopes of PA. Sera from anthrax-vaccinated rabbits inhibited the binding of fluorescent mAbs to either epitope; the degree of inhibition correlated with the dilution of sera.
CONCLUSIONS: The response in the rabbit sera to either epitope on PA depended on the dose of vaccine administered to the rabbits. No inhibition was seen with sera from control animals. With no species-specific components, this assay could be adapted readily for comparing responses between species. Published 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12210604     DOI: 10.1002/cyto.10134

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  5 in total

Review 1.  Rabbit and nonhuman primate models of toxin-targeting human anthrax vaccines.

Authors:  Andrew J Phipps; Christopher Premanandan; Roy E Barnewall; Michael D Lairmore
Journal:  Microbiol Mol Biol Rev       Date:  2004-12       Impact factor: 11.056

2.  Anthrax toxin-neutralizing antibody reconfigures the protective antigen heptamer into a supercomplex.

Authors:  Mazdak Radjainia; Jae-Kyung Hyun; Clinton E Leysath; Stephen H Leppla; Alok K Mitra
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

3.  Identification of linear epitopes in Bacillus anthracis protective antigen bound by neutralizing antibodies.

Authors:  Nareen Abboud; Magdia De Jesus; Antonio Nakouzi; Radames J B Cordero; Mario Pujato; András Fiser; Johanna Rivera; Arturo Casadevall
Journal:  J Biol Chem       Date:  2009-07-18       Impact factor: 5.157

4.  Synthetic peptide vaccine targeting a cryptic neutralizing epitope in domain 2 of Bacillus anthracis protective antigen.

Authors:  Jon Oscherwitz; Fen Yu; Jana L Jacobs; Te-Hui Liu; Philip R Johnson; Kemp B Cease
Journal:  Infect Immun       Date:  2009-06-01       Impact factor: 3.441

Review 5.  Analysis of epitope information related to Bacillus anthracis and Clostridium botulinum.

Authors:  Laura M Zarebski; Kerrie Vaughan; John Sidney; Bjoern Peters; Howard Grey; Kim D Janda; Arturo Casadevall; Alessandro Sette
Journal:  Expert Rev Vaccines       Date:  2008-02       Impact factor: 5.217

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.